Lan et al. [99] developed a stimulus-responsive therapeutic platform utilizing nanomicelles that integrate mechanisms responsive to the low pH and elevated activity of MMP-13 characteristic of the inflammatory microenvironment in arthritis. This evidence concerns the gene MMP13 and arthritic joint disease.